Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

MYLAN-ATAZANAVIR DIN 02456877

Status: Marketed
Holder: MYLAN PHARMACEUTICALS ULC
Molecule: ATAZANAVIR (ATAZANAVIR SULFATE)
Available to quote

Health Canada record

Active ingredient(s)ATAZANAVIR (ATAZANAVIR SULFATE) 150 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCJ05AE08 ATAZANAVIR
Original market date03-May-2017
Current status date03-May-2017
SourceHealth Canada DPD

Establishment licence of the holder

Mylan Pharmaceuticals ULC — licence 101774, currently licensed, last inspection rating C (2026-02-24).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ATAZANAVIR (ATAZANAVIR SULFATE)

DINProductCompanyFormStrengthStatus
02479249APO-ATAZANAVIRAPOTEX INCCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 150 MGApproved
02479265APO-ATAZANAVIRAPOTEX INCCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 300 MGApproved
02479257APO-ATAZANAVIRAPOTEX INCCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 200 MGApproved
02456893MYLAN-ATAZANAVIRMYLAN PHARMACEUTICALS ULCCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 300 MGMarketed
02456885MYLAN-ATAZANAVIRMYLAN PHARMACEUTICALS ULCCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 200 MGMarketed
02443813TEVA-ATAZANAVIRTEVA CANADA LIMITEDCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 200 MGMarketed
02443821TEVA-ATAZANAVIRTEVA CANADA LIMITEDCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 300 MGMarketed
02443791TEVA-ATAZANAVIRTEVA CANADA LIMITEDCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 150 MGMarketed
02446731EVOTAZBRISTOL-MYERS SQUIBB CANADATabletATAZANAVIR (ATAZANAVIR SULFATE) 300 MG; COBICISTAT 150 MGCancelled Post Market
02513129JAMP ATAZANAVIRJAMP PHARMA CORPORATIONCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 300 MGDormant
02513102JAMP ATAZANAVIRJAMP PHARMA CORPORATIONCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 150 MGDormant
02513110JAMP ATAZANAVIRJAMP PHARMA CORPORATIONCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 200 MGDormant
02248610REYATAZBRISTOL-MYERS SQUIBB CANADACapsuleATAZANAVIR (ATAZANAVIR SULFATE) 150 MGCancelled Post Market
02248609REYATAZBRISTOL-MYERS SQUIBB CANADACapsuleATAZANAVIR (ATAZANAVIR SULFATE) 100 MGCancelled Pre Market
02294176REYATAZBRISTOL-MYERS SQUIBB CANADACapsuleATAZANAVIR (ATAZANAVIR SULFATE) 300 MGCancelled Post Market
02248611REYATAZBRISTOL-MYERS SQUIBB CANADACapsuleATAZANAVIR (ATAZANAVIR SULFATE) 200 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
191692017-04-18Abbreviated New Drug Submission (ANDS)
Request a quote for MYLAN-ATAZANAVIR

How to read a Canadian DIN record